Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BIAFW | US
0.09
36.10%
Healthcare
Diagnostics & Research
30/06/2024
13/03/2026
0.33
0.39
0.39
0.31
Positive Momentum
Strength based on increasing price with high volume
Strong Revenue Growth (> 10%)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
467.9%1 month
393.6%3 months
376.6%6 months
368.8%-
-
-
0.40
0.21
-
-
-
-8.03M
-
-
-
-87.08
-
12.05K
-151.52
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.18
Range1M
0.18
Range3M
0.18
Rel. volume
1.75
Price X volume
1.02K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| STRRP | STRRP | Diagnostics & Research | 10.06 | 0 | 0.20% | n/a | 26.85% |
| Prenetics Holding Company Limited | PRENW | Diagnostics & Research | 0.0202 | 0 | n/a | 0.63% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
No data | |||||||
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | - | 12.67 | - |
| Ent. to Revenue | - | 44.00 | - |
| PE Ratio | - | 40.09 | - |
| Price to Book | - | 77.50 | - |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 376.56 | 59.59 | Riskier |
| Debt to Equity | 0.40 | -14.36 | Expensive |
| Debt to Assets | 0.21 | 0.34 | Cheaper |
| Market Cap | - | 13.71B | - |